JOHNSON & JOHNSON — Director's Dealing 2018

Jul 12, 2018

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: JOHNSON & JOHNSON (JNJ)
CIK: 0000200406
Period of Report: 2018-07-02

Reporting Person: McEvoy Ashley (EVP, WW Chair, Medical Devices)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	9476.1146	Direct
Common Stock	2340.0000	Indirect
Common Stock	300.0000	Indirect

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Employee Stock Options (Right to Buy)	$72.5400	2023-01-13	Common Stock (73323.0000)		Direct
Employee Stock Options (Right to Buy)	$90.4400	2024-02-09	Common Stock (49225.0000)		Direct
Employee Stock Options (Right to Buy)	$100.0600	2025-02-09	Common Stock (46803.0000)		Direct
Employee Stock Options (Right to Buy)	$101.8700	2026-02-08	Common Stock (43689.0000)		Direct
Employee Stock Options (Right to Buy)	$115.6700	2027-02-13	Common Stock (37361.0000)		Direct
Employee Stock Options (Right to Buy)	$129.5100	2028-02-11	Common Stock (41889.0000)		Direct
Restricted Share Units	$		Common Stock (38650.0000)		Direct
Restricted Share Units	$		Common Stock (6599.0000)		Direct
Restricted Share Units	$		Common Stock (2102.0000)		Direct
Restricted Share Units	$		Common Stock (6602.0000)		Direct

Footnotes

F1: Shares held in the Johnson & Johnson Stock Fund under the Johnson & Johnson Savings Plan as of the Plan's most recent reporting date (6/30/2018).

F2: Shares held by ESOP under the Johnson & Johnson Savings Plan as of the Plan's most recent reporting date (6/30/2018).

F3: Vested and exercisable one day after the third anniversary of the date of the grant.

F4: Each Restricted Share Unit represents a contingent right to receive one share of Company Common Stock and vests on the third anniversary of the date of grant.